Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia Areata often runs in families and is linked to other autoimmune conditions.

People with Alopecia Areata are more likely to have autoimmune diseases, inflammatory diseases, and mental health issues like anxiety and depression.

Alopecia areata causes sudden hair loss, often on the scalp, and can be severe, especially with early onset or related health issues.

FAPD and possibly CCCA may be AGA subtypes, and treatments combining antiandrogens, hair growth agents, hair transplants, and anti-inflammatories could be effective.

Alopecia areata patients have a higher risk of other immune-related diseases.

Alopecia areata might help slow down certain cancers.

Understanding the genetics of alopecia areata could lead to better treatments.

Targeting specific metabolic and ionic pathways may improve alopecia areata treatment.

Not all cases with typical signs of Alopecia Areata are actually diagnosed as such.

Researchers found that certain miRNAs, which affect immune system regulation, are differently expressed in mice with a hair loss condition compared to healthy mice.

New drugs, baricitinib and ritlecitinib, are effective for severe alopecia areata.

Stress may contribute to hair loss in alopecia areata by affecting immune responses and cell death in hair follicles.

Certain factors like patchy hair loss at the back of the head, being female, and younger age at diagnosis can lead to a worse outcome for alopecia areata.

People who get alopecia areata after age 50 usually have mild symptoms, high chances of hair regrowth, and often have other health conditions.

Lacrimal gland inflammation and alopecia areata can happen together due to autoimmune issues.

Alopecia areata is a common autoimmune disease affecting hair follicles, with unclear causes and a need for better treatments.

Plasmacytoid dendritic cells are a key factor in causing hair loss in alopecia areata and could help differentiate it from other hair loss conditions.

Targeting specific metabolic and ionic pathways may improve alopecia areata treatment.

Alopecia areata is linked to autoimmune antibodies.

The study concluded that a 'Swiss cheese' pattern in hair follicles is a useful sign for diagnosing alopecia areata.

Scientists are still unsure what triggers the immune system to attack hair follicles in Alopecia areata.

Anti-TNF-α therapy may increase the risk of developing alopecia areata, especially in those with a history of autoimmune disease.

Azelaic acid's effectiveness in treating certain skin conditions needs more research.

Alopecia areata is a chronic condition causing hair loss, with new treatments targeting the immune system showing promise.

Androgenetic alopecia causes hair thinning due to increased androgen activity, treatable with minoxidil and finasteride.

Alopecia Areata is an autoimmune hair loss condition, with various treatments showing mixed effectiveness and no guaranteed cure.

Hypothyroidism patients with hair loss typically have thinning hair, smaller hair follicles, and normal hair shedding.

People with alopecia areata are more likely to get migraines, and vice versa.

Vitamin D may help reduce severity and relapse of alopecia areata.

Alopecia areata progression is linked to stress and hormone changes, suggesting new treatment targets.